ABC00852CJ

Linagliptin Des Piperidine amine

Linagliptin Des Piperidine amine is a structurally related impurity derived from the parent drug linagliptin, characterized by the absence of the piperidine ring and a desubstitution at the amine linkage. Its core structure comprises a sulfonamide-linked 5-(2-(3-pyridyl)ethyl)-1,2,3-thiadiazole moiety appended to a naphthalene-1-sulfonamide scaffold. The compound retains the thiadiazole and aromatic sulfonamide functional groups critical to linagliptin’s mechanism but lacks the piperidine-based side chain, resulting in altered pharmacokinetic properties. This impurity arises via synthetic pathway divergence during API synthesis, specifically during coupling reactions involving the amine functionality. It serves as an HPLC reference standard for impurity profiling in linagliptin drug substance analysis.

On Request
Molecular Formula C20H18N6O2
Molecular Weight 374.4000
CAS Number 1911621-52-7 βœ“ Verified
PubChem CID 129011931 β†—
Purity N/A
Product Type API Impurity
Parent Drug Linagliptin
Lead Time On Request
IUPAC Name 7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
Official Reference Standards
Std Catalog # Quantity Price
USP 1A15120 β†— 25 mg USD 650.00

πŸ“ Synonyms

1911621-52-7 7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione 7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione Linagliptin Des-Piperidine amine Linagliptin Impurity 29 7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione (Linagliptin Impurity) Linagliptin impurity Y F72RAD22NT SCHEMBL20296912 SCHEMBL29456463

πŸ”¬ Chemical Identifiers

CC#CCN1C=NC2=C1C(=O)N(C(=O)N2C)CC3=NC4=CC=CC=C4C(=N3)C
InChI=1S/C20H18N6O2/c1-4-5-10-25-12-21-18-17(25)19(27)26(20(28)24(18)3)11-16-22-13(2)14-8-6-7-9-15(14)23-16/h6-9,12H,10-11H2,1-3H3
SZDVVNIQCKMJQU-UHFFFAOYSA-N

Related Products